Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 8:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1057–1080 of 1,170 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Sham Control Group Clear all

Conditions: Depression, Major Depressive Disorder
Interventions: Transcranial Light Therapy, Sham Transcranial Light Therapy; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 70 Years
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Boston, Massachusetts • Orangeburg, New York

Conditions: Attention Deficit Disorder With Hyperactivity
Interventions: 8 weeks of home based use.; Device
Lead sponsor: Michigan State University; Other
Eligibility: 8 Years to 17 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: East Lansing, Michigan

Conditions: Ischemic Cardiomyopathy
Interventions: Intramyocardial Injection of stem cells via NOGA Mapping, Control, then Stem Cell Therapy; Device · Other
Lead sponsor: Texas Heart Institute; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Diabetic Macular Edema
Interventions: IVT aflibercept, Sham SC, SC CLS-TA; Drug
Lead sponsor: Clearside Biomedical, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 29
States / cities: Phoenix, Arizona • Tucson, Arizona • Bakersfield, California + 25 more

Conditions: ADHD
Interventions: methylphenidate transdermal system, Placebo; Drug
Lead sponsor: Noven Therapeutics; Industry
Eligibility: 13 Years to 17 Years
Enrollment: 217 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 32
States / cities: Scottsdale, Arizona • Lafayette, California • Wildomar, California + 29 more

Conditions: TBI Depression
Interventions: Low Frequency Right sided repetitive transcranial magnetic stimulation (LFR rTMS), Sham Comparator: Sham Treatment; Combination Product · Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pain
Interventions: Paracervical Nerve Block, Sham Paracervical Block; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 14 Years to 22 Years · Female only
Enrollment: 98 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 3
States / cities: Philadelphia, Pennsylvania

Conditions: Post Traumatic Stress Disorder, Cardiovascular Diseases, Autonomic Dysfunction, Vascular Stiffness, Nightmare, Endothelial Dysfunction, Kidney Diseases, Renal Dysfunction, Trauma and Stressor Related Disorders
Interventions: NightWare, Sham NightWare; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 22 Years to 40 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: DENT IMPLANTS, LASER
Interventions: Conventional mechanical therapy, Saline, Methylene Blue, Light emitting laser, Non-light emitting laser; Procedure · Drug · Device
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Cerebral Stroke
Interventions: CARET, CTI, Sham CARET, Sham CTI; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 2
States / cities: Miami, Florida

Conditions: Post-Traumatic Stress Disorders, Stress Disorders, Traumatic, Post Traumatic Stress Disorder, PTSD, Trauma and Stressor Related Disorders
Interventions: Working Memory Training, Sham Training; Behavioral · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: San Diego, California

Conditions: Postoperative Pain, Acute, Shoulder Pain
Interventions: intercostobrachial nerve block; Procedure
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Breast Cancer, Depression, Fatigue
Interventions: Bio-field energy therapy, fatigue assessment and management, psychosocial assessment and care, quality-of-life assessment, therapeutic touch; Procedure
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 21 Years to 75 Years · Female only
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 3
States / cities: Nashville, Tennessee

Conditions: Fibromyalgia, Healthy Volunteers
Interventions: EEG, Neuroimaging EEG/fMRI (Aim 1), HD-tDCS treatments, Sham HD-tDCS treatments, Neuroimaging EEG/fMRI (Aim 3); Diagnostic Test · Device
Lead sponsor: University of Michigan; Other
Eligibility: 19 Years to 74 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Stroke, Hemiparesis
Interventions: In Motion Rehabilitation Robot; Device
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 85 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Manhasset, New York

Conditions: Obesity
Interventions: Auricular Acupuncture, Sham Acupuncture; Other
Lead sponsor: Mike O'Callaghan Military Hospital; Federal
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Postoperative Pain, Fibroid Uterus
Interventions: Bupivacain, Saline; Drug
Lead sponsor: Joseph Findley MD; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Beachwood, Ohio

Conditions: Motor Activity
Interventions: Motor Learning, Somatosensory Learning, Observational Task, Mental Imagery, transcranial direct current stimulation; Behavioral · Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 64 Years · Male only
Enrollment: 115 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Mild Traumatic Brain Injury (mTBI), Post-traumatic Stress Disorder
Interventions: TES; Device
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 60 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: Knee Osteoarthritis
Interventions: Femoral Nerve Catheters, Single Shot Femoral Nerve Blocks; Drug
Lead sponsor: Eastern Maine Medical Center; Other
Eligibility: 18 Years to 80 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Bangor, Maine

Conditions: Nasal Airway Obstruction
Interventions: Vivaer ARC Stylus, Sham; Device
Lead sponsor: Aerin Medical; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 12
States / cities: Roseville, California • Torrance, California • Coral Springs, Florida + 9 more

Conditions: Alzheimer Disease
Interventions: Lithia water, Transcranial Magnetic stimulation; Dietary Supplement · Device
Lead sponsor: American Society Of Thermalism And Climatology Inc; Other
Eligibility: 50 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Pain, Postoperative, Anterior Cruciate Ligament Injuries, Analgesics, Opioid
Interventions: IPACK, PLACEBO; Drug
Lead sponsor: Loyola University; Other
Eligibility: 16 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: Tourette Syndrome
Interventions: Active Treatment, Sham Treatment; Device
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 8 Years to 20 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Kansas City, Missouri

Search by objective public record fields.

Transcranial Laser Therapy, Continuous and Pulsed Light, for Major Depressive Disorder (ELATED-3)

Efficacy of the Apollo System for Children With ADHD

Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)

Suprachoroidal CLS-TA With Intravitreal Aflibercept Versus Aflibercept Alone in Subject With Diabetic Macular Edema

Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD

Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Depression & Other Neuropsychiatric Symptoms After Traumatic Brain Injury (TBI)

Study of Pain Control With Hormonal IUS Insertion

NightWare and Cardiovascular Health in Women With PTSD

Clinical and Microbiologic Outcomes of aPDT in the Non-surgical Treatment of Implant Inflammation

The Safety and Tolerability of an Aerobic and Resistance Exercise Program With Cognitive Training Post-stroke

Cognitive Control Training for Extinction in PTSD

Evaluating Intercostobrachial Nerve Block's Effect on Pain Control After Shoulder Replacement

Healing Touch in Treating Fatigue in Women Undergoing Radiation Therapy for Breast Cancer

Explosive Synchronization of Brain Network Activity in Chronic Pain

Trans Auricular Vagus Nerve Stimulation (taVNS) and Robotic Training for Paralyzed Arm After Stroke

Auricular Acupuncture in the Treatment of Obesity

QL Block in Laparoscopic Myomectomy

Investigating Motor Cortex Processing for Pain Modulation

Transcranial Electrical Stimulation for mTBI

Comparing Femoral Nerve Catheters to Single Shot Femoral Nerve Blocks for Total Knee Replacement Surgery

Vivaer® Procedure for Treatment of Nasal Airway Obstruction Study

LIWA for Treatment of Alzheimer Patients

IPACK on Early Pain Scores After ACL Reconstruction

Multi-site Transcranial Magnetic Stimulation Therapy of the Supplementary Motor Area in Children With Tourette Syndrome